| Molecular formula | C225H360N76O67S |
|---|
| Molecular weight | 5234 g/mol |
|---|
| Registered trials | 371 |
|---|
| PubChem CID | 16132356 |
|---|
What somatropin recombinant is
Somatropin recombinant is being discussed here as a research compound. No approved product label was available for this entry, so approved-use claims cannot be made from this data set. Chemically, it is a large peptide with the molecular formula C225H360N76O67S and a molecular weight of approximately 5,234 daltons (PubChem CID 16132356). Its size and sequence place it in the category of recombinant protein peptides rather than small-molecule drugs.
Trial footprint
There are 371 registered clinical trials associated with this compound. Among the sampled records, one completed real-world study examined a long-acting growth hormone injection in the context of Turner syndrome. Another completed phase 3 trial looked at long-term outcomes in adults with growth hormone deficiency, and a completed phase 4 trial examined growth hormone treatment in children diagnosed with intrauterine growth retardation. These entries indicate an active and long-running trial history rather than a single isolated study. Naming these trials does not imply that any outcome was positive or that the compound is effective for the studied conditions.
FAQ
This entry is based on research and trial registry data rather than an approved product label. No approved-use information is available from the data reviewed here. Readers should not treat this as an indication of approval status one way or the other beyond what is stated.
Registry data lists 371 clinical trials associated with this compound. These span a range of study designs and completion statuses, including completed phase 3 and phase 4 trials. The total count reflects registered studies, not confirmed findings.
It is a large peptide with the molecular formula C225H360N76O67S and a molecular weight of about 5,234 daltons. Its size places it among recombinant protein peptides rather than small synthetic molecules. The PubChem CID for this compound is 16132356.
Sampled trial records include studies related to Turner syndrome, growth hormone deficiency in adults, and intrauterine growth retardation in children. These are examples from the registered trial sample, not a complete list of all study populations. Their inclusion does not indicate an approved use.
No adverse event report data was available in the data set reviewed for this entry. As a result, no side effect summary can be provided here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: ClinicalTrials.gov PubChem
Updated 2026-09-19